Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
09/2010
09/29/2010EP2231636A1 Pyrazole derivatives and use thereof as inhibitors of cyclin dependent kinases
09/29/2010EP2231629A1 Modulators for amyloid beta
09/29/2010EP2231620A1 Diaminopyridines for the treatment of diseases which are characterised by excessive or anomal cell proliferation
09/29/2010EP2231615A1 Cannabinoid receptor modulators
09/29/2010EP2231602A1 Gamma secretase modulators
09/29/2010EP2231600A1 Carboxamide, sulfonamide and amine compounds for metabolic disorders
09/29/2010EP2231558A1 3,4-substituted pyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease
09/29/2010EP2231161A1 A process of making imatinib
09/29/2010EP2004641B1 Hiv inhibiting 5-(hydroxymethylene and aminomethylene) substituted pyrimidines
09/29/2010EP1966193B1 New salt and polymorph of dpp-iv inhibitor
09/29/2010EP1893200B1 Carbamate derivatives as positive allosteric modulators of metabotropic glutamate receptors
09/29/2010EP1628957B1 Sulfopyrroles
09/29/2010EP1615889B1 Biphenyl derivatives having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
09/29/2010EP1534695B1 Tyrosine kinase inhibitors
09/29/2010EP1086950B1 Heterocyclic indole derivatives and mono- or diazaindole derivatives
09/29/2010CN1882569B 喹唑啉衍生物 Quinazoline derivatives
09/29/2010CN1865259B Process for preparing piperidine derivative
09/29/2010CN1821217B Process for producing trans-4-amino-1-cyclohexanecarboxylic acid derivative
09/29/2010CN101848907A Compounds with a combination of cannabinoid-CB1 antagonism and acetylcholinesterase inhibition
09/29/2010CN101848898A Phthalazinone derivatives as inhibitors of PARP-1
09/29/2010CN101848897A Gamma secretase modulators
09/29/2010CN101848896A Isoquinolinyl and isoindolinyl derivatives as histamine-3 antagonists
09/29/2010CN101848894A New anticoagulant compounds, pharmaceutical compositions on their basis to treat thrombotic conditions, and plasma-substituting solution to correct hypercoagulation defects of hemodilution
09/29/2010CN101848893A 1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones
09/29/2010CN101845023A Tetrazole compounds and their use as metabotropic glutamate receptor antagonists
09/29/2010CN101312233B Organic electroluminescent device and display apparatus
09/29/2010CN101274931B Preparing process for rupatadine
09/29/2010CN101074227B Phosphine acyloxy quinazoline derivatives and their medicine uses
09/29/2010CN101070315B Method for preparing omeprazole
09/29/2010CN101061110B Heterlcyclic diamide insecticides
09/29/2010CN101061106B Potentiators of glutamate receptors
09/29/2010CN101035762B Alkil-pyridines as 11-beta inhibitors for diabetes
09/29/2010CN101006082B Histamine H3 receptor agents, preparation and therapeutic uses
09/29/2010CN101006076B Modulators of ATP-binding cassette transporters
09/28/2010US7803954 Mandelic acid derivatives and their use as thrombin inhibitors
09/28/2010US7803944 Viral polymerase inhibitors
09/28/2010US7803940 Heteromonocyclic compound or a salt thereof having strong antihypertensive action, insulin sensitizing activity and the like production thereof and use thereof for prophylaxis or treatment of cardiovascular diseases, metabolic diseases and/or central nervous system diseases
09/28/2010US7803939 N2,N4-bis(4-ethoxyphenyl)-5-fluoro-2,4-pyrimidinediamine; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors
09/28/2010US7803841 EP2 receptor agonists
09/28/2010US7803832 N-(1-arylpyrazol-4L)sulfonamides and their use as parasiticides
09/28/2010US7803831 3-(2-hydroxy-phenyl)-1H-pyrazole-4-carboxylic acid amide derivatives as HSP90 inhibitors for the treatment of cancer
09/28/2010US7803821 N-cyclopropyl-N-[(3,4-dimethoxypyridin-2-yl)methyl]-5-fluoro-1,3-dimethyl-1H-pyrazole-4-carboxamide; control of phytopathogenic fungi of plants
09/28/2010US7803819 dipeptidyl peptidase IV (DPP-IV) inhibitors, such as 2S)-1-{[(1S)-2-(5-cyano-2-methyl-indol-1-yl)-1-methyl-ethylamino]-acetyl}-pyrrolidine-2-carbonitrile, useful for the treatment and/or prophylaxis non-insulin dependent diabetes and impaired glucose tolerance; antidiabetic agents
09/28/2010US7803814 Tricyclic steroid hormone nuclear receptor modulators
09/28/2010US7803813 selective serotonin receptor agonists, such as 2-chloro-4-fluoro-N-(3-(1-methylpiperidin-4-ylamino)phenyl)benzamide fumarate, used fot the treatment or prevention of neuronal protein extravasation and/or headaches
09/28/2010US7803807 such as trans-2-[3'-oxospiro [cyclohexane- 1,1'(3'H)-isobenzofuran]-4yl]-5-(2-pyridyl) imidazo[4,5-b]pyridine, exhibiting neuropeptide Y antagonistic effects, used for the treatment of cardiovascular, nervous system, metabolic, gastrointestinal, sexual and respiratory system disorders; pharmacokinetics
09/28/2010US7803801 Spleen tyrosine kinase (syk) inhibitors such as 1-methyl-4-{5-[6-(4-methylpyridin-2-ylamino)pyridin-2-yl]thiazol-2-yl}piperazin-2-one, used for the treatment of allergic or inflammatory diseases
09/28/2010US7803793 For example, 4-(4-Chloro-phenoxy)-N-(1-hydroxy-2-oxo-2,3,4,7-tetrahydro-1H-azepin-3-(R)-yl)-benzenesulfonamide; for treating disorders related to matrix metalloproteases, particularly useful for treating strokes
09/28/2010CA2574875C Aryl-pyridine derivatives as 11-beta hsd1 inhibitors
09/28/2010CA2553160C 2-heteroaryl-substituted benzimidazole derivative
09/28/2010CA2536929C 2-substituted benzimidazole piperidines analogs as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
09/28/2010CA2527587C Heteroaryl-substituted imidazole derivatives as glutamate receptor antagonists
09/28/2010CA2395772C Sulfonamide-containing heterocyclic compounds
09/28/2010CA2387016C Acrylamide derivatives as fab i inhibitors
09/28/2010CA2386417C Phenyl- and pyridyl-tetrahydropyridines having tnf-inhibiting activity
09/28/2010CA2383524C Thiazolyl alkynyl compounds and methods of use thereof
09/23/2010WO2010107768A1 Bicyclic compounds as inhibitors of diacylglycerol acyltransferase
09/23/2010WO2010107384A1 Aspartyl protease inhibitors
09/23/2010WO2010107074A1 Compound having benzotriazole ring structure and organic electroluminescent element
09/23/2010WO2010106290A1 Hsp90 inhibiting indazole derivatives, compositions containing same and use thereof
09/23/2010WO2010106269A2 Derivatives of n-[(2-aza-bicyclo[2.1.1]hex-1-yl)-aryl-methyl]-heterobenzamide, preparation thereof and application of same in therapeutics
09/23/2010WO2010106106A1 2, 5-disubstituted tetrazole derivatives and their use as nicotinic acetylcholine receptor modulators
09/23/2010WO2010106097A1 Substituted pyrimidines for the treatment of cancer
09/23/2010WO2010106081A1 Piperidine derivatives as nk3 receptor antagonists
09/23/2010WO2010083872A3 Materials for organic electroluminescence devices
09/23/2010WO2009132774A8 New substituted indolin-2-one derivatives and their use as p38 mitogen-activated kinase inhibitors
09/23/2010WO2009127948A8 4- [3- (aryloxy) benzylidene] -3-methyl piperidine 5-membered aryl carboxamide compounds useful as faah inhibitors
09/23/2010US20100240688 1,3-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h,1 h-1,4 bipyridinyl-2-ones
09/23/2010US20100240679 4-Phenylpiperidine Derivatives as Renin Inhibitors
09/23/2010US20100240677 Compounds as PDE IV and TNF Inhibitors
09/23/2010US20100240676 Thiazole derivatives
09/23/2010US20100240675 Therapeutic agents useful for treating pain
09/23/2010US20100240670 4-[(arylmethyl)aminomethyl]piperidine derivatives, their preparation and their therapeutic application
09/23/2010US20100240669 New compounds
09/23/2010US20100240657 Chemical compounds
09/23/2010US20100240656 Compounds as hsp90 inhibitors
09/23/2010US20100240653 Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine h3-receptor useful for the treatment of disorders related thereto
09/23/2010US20100240651 Water-soluble thalidomide derivatives
09/23/2010US20100240650 Substituted pyrrolines as kinase inhibitors
09/23/2010US20100240649 Quinazoline and quinoline derivatives as irreversible protein tyrosine kinase inhibitors
09/23/2010US20100240646 Pyrrolo-triazine aniline compounds useful as kinase inhibitors
09/23/2010US20100240642 1H-Indole-2-Carboxylic Acid Derivatives Useful As PPAR Modulators
09/23/2010US20100240640 (THIO) Carbamoyl-Cyclohexane Derivatives as D3/D2 Receptor Antagonists
09/23/2010US20100240639 Sulfonyl-Derivatives as Novel or Histone Deacetylase
09/23/2010US20100240637 Inhibitors of the Interaction Between MDM2 and P53
09/23/2010US20100240634 Fluorene Compound and Pharmaceutical Use Thereof
09/23/2010US20100240619 Fungicidal mixtures
09/23/2010US20100240618 Substituted piperazines
09/23/2010US20100240580 Azoloarine derivatives, method for the production thereof, pharmaceuticals containing these compounds and the use thereof
09/23/2010US20100240139 Free radical initiator and method for peptide sequencing using the same
09/23/2010US20100240137 Derivatization-enhanced analysis of amino acids and peptides
09/23/2010US20100239576 Amino ester derivatives, sailts thereof and methods of use
09/23/2010US20100239551 Compounds and compositions as channel activating protease inhibitors
09/23/2010US20100239496 Imaging agents for detecting neurological disorders
09/23/2010CA2755759A1 Substituted pyrimidines for the treatment of cancer
09/23/2010CA2755660A1 Hsp90 inhibiting indazole derivatives, compositions containing same and use thereof
09/23/2010CA2755526A1 Derivatives of n-[(2-aza-bicyclo[2.1.1]hex-1-yl)-aryl-methyl]-heterobenzamide, preparation thereof and application of same in therapeutics
09/23/2010CA2755253A1 Bicyclic compounds as inhibitors of diacylglycerol acyltransferase
09/23/2010CA2754509A1 Novel anti-inflammatory agents
09/23/2010CA2749650A1 Piperidine derivatives as nk3 receptor antagonists
1 ... 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 ... 1080